79 Macular Edema Secondary to Inflammation How does KSI-101 fit into the emerging treatment landscape? Sumit Sharma MD
Investor R&D Day Presentation Page 77 Page 7979 Macular Edema Secondary to Inflammation How does KSI-101 fit into the emerging treatment landscape? Sumit Sharma MD
Investor R&D Day Presentation Page 77 Page 79